HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,101 | -83.0% | 459 | -84.8% | 0.00% | -80.0% |
| Q2 2023 | $311,533 | +30145.9% | 3,029 | -67.9% | 0.01% | -69.7% |
| Q1 2023 | $1,030 | +43.5% | 9,439 | +49.5% | 0.03% | +10.0% |
| Q4 2022 | $718 | -99.9% | 6,313 | -44.8% | 0.03% | +172.7% |
| Q3 2022 | $708,000 | -41.9% | 11,437 | -25.1% | 0.01% | -59.3% |
| Q2 2022 | $1,218,000 | +84.3% | 15,277 | +143.0% | 0.03% | +350.0% |
| Q1 2022 | $661,000 | -38.7% | 6,287 | -37.1% | 0.01% | -68.4% |
| Q4 2021 | $1,078,000 | +516.0% | 9,996 | +524.4% | 0.02% | +375.0% |
| Q3 2021 | $175,000 | -87.0% | 1,601 | -88.9% | 0.00% | -88.6% |
| Q2 2021 | $1,349,000 | +312.5% | 14,407 | +305.4% | 0.04% | +483.3% |
| Q1 2021 | $327,000 | -29.4% | 3,554 | -43.9% | 0.01% | -57.1% |
| Q4 2020 | $463,000 | -45.7% | 6,332 | -42.3% | 0.01% | +55.6% |
| Q3 2020 | $853,000 | +1450.9% | 10,976 | +1016.6% | 0.01% | +350.0% |
| Q2 2020 | $55,000 | -51.8% | 983 | -74.6% | 0.00% | -71.4% |
| Q1 2020 | $114,000 | +500.0% | 3,874 | +642.1% | 0.01% | +250.0% |
| Q4 2019 | $19,000 | -74.0% | 522 | -80.4% | 0.00% | -60.0% |
| Q3 2019 | $73,000 | -11.0% | 2,668 | -21.3% | 0.01% | -16.7% |
| Q2 2019 | $82,000 | – | 3,389 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |